Imperva (NASDAQ: IMPV) is one of 185 publicly-traded companies in the “IT Services & Consulting” industry, but how does it contrast to its competitors? We will compare Imperva to similar companies based on the strength of its profitability, institutional ownership, valuation, earnings, risk, analyst recommendations and dividends.

Risk and Volatility

Imperva has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. Comparatively, Imperva’s competitors have a beta of 1.13, indicating that their average stock price is 13% more volatile than the S&P 500.

Earnings & Valuation

This table compares Imperva and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Imperva $264.45 million -$70.27 million 149.81
Imperva Competitors $2.79 billion $290.02 million 333.04

Imperva’s competitors have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

97.0% of Imperva shares are owned by institutional investors. Comparatively, 61.5% of shares of all “IT Services & Consulting” companies are owned by institutional investors. 1.9% of Imperva shares are owned by insiders. Comparatively, 17.0% of shares of all “IT Services & Consulting” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Imperva and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva 3.04% -8.52% -4.99%
Imperva Competitors -21.00% -276.25% -4.94%

Analyst Recommendations

This is a summary of current recommendations for Imperva and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 2 6 8 0 2.38
Imperva Competitors 744 4669 7442 166 2.54

Imperva presently has a consensus target price of $51.33, indicating a potential upside of 26.91%. As a group, “IT Services & Consulting” companies have a potential downside of 5.23%. Given Imperva’s higher possible upside, equities research analysts plainly believe Imperva is more favorable than its competitors.

Summary

Imperva competitors beat Imperva on 7 of the 12 factors compared.

Imperva Company Profile

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.